Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

AI In Genomics Market is Expected to Reach $2.0 Billion | MarketsandMarkets.

Published

on

Chicago, July 24, 2023 (GLOBE NEWSWIRE) — In the near future, the genomics industry is set to undergo a transformative revolution driven by the rapid integration of Artificial Intelligence (AI) technologies. AI will play a pivotal role in advancing various aspects of genomics research, diagnosis, and treatment, leading to groundbreaking discoveries and personalized medicine. With the ability to process vast volumes of genomic data quickly and accurately, AI algorithms will enhance our understanding of complex genetic patterns and their correlations with diseases, unlocking new insights into human biology. AI-powered predictive models will enable more precise risk assessments for various genetic conditions, facilitating early disease detection and prevention. Moreover, AI-driven drug development platforms will expedite the identification of novel therapeutic targets, leading to the creation of highly targeted and effective treatments. As AI becomes an indispensable tool for genomics, its potential to revolutionize the field is boundless, offering tremendous opportunities to improve human health and revolutionize healthcare as we know it.

AI In Genomics market in terms of revenue was estimated to be worth $0.5 Billion in 2023 and is poised to reach $2.0 Billion by 2028, growing at a CAGR of 32.3% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Factors such as need to accelerate processes and timeline and reduce drug development and discovery costs, increasing partnerships and collaborations among players and growing investments in AI in genomics primarily drive the growth of this market. Furthermore, rising adoption of AI in precision medicine, explosion in bioinformatics data and genomic datasets drive market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899

AI In Genomics Market Scope:

Report Coverage Details
Market Revenue in 2023 $0.5 Billion
Estimated Value by 2028 $2.0 Billion
Growth Rate Poised to grow at a CAGR of 32.3%
Market Size Available for 2021–2028
Forecast Period 2023–2028
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Offering, Technology, Functionality, Application, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunities Focus on developing human-aware AI systems
Key Market Drivers Need to accelerate processes and timeline and reduce drug development and discovery costs

AI In Genomics market major players covered in the report, such as:

  • NVIDIA Corporation (US)
  • Microsoft Corporation (US)
  • Google Inc. (US)
  • Intel Corporation (US)
  • BenevolentAI (UK)
  • SOPHiA GENETICS (Switzerland)
  • Illumina Inc. (US)
  • Predictive Oncology Inc. (US)
  • Invitae Corporation (US)
  • Deep Genomics Inc. (Canada)
  • Fabric Genomics Inc. (US)
  • Verge Genomics (US)
  • Freenome Holdings Inc. (US)
  • MolecularMatch Inc. (US)
  • Dante labs (US)
  • Data4Cure (US)
  • PrecisionLife Ltd (UK)
  • Genoox (US)
  • Lifebit (UK)
  • FDNA Inc. (US)
  • DNAnexus (US)
  • Engine Biosciences (US)
  • Tempus Labs Inc. (US)
  • Congenica Ltd (England)
  • Emedgene Inc. (US)
  • Seragon Pharmaceuticals Inc. (US)
  • and Among Others

Buy AI In Genomics Industry Report (240 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=36649899

This research report categorizes the global artificial intelligence (AI) in genomics market by offering, technology, functionality, application, end user, and region

On the basis of offering, the global artificial intelligence (AI) in genomics market has been segmented as follows:

  • Software
  • Services

On the basis of technology, the global artificial intelligence (AI) in genomics market has been segmented as follows:

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

On the basis of functionality, the global artificial intelligence (AI) in genomics market has been segmented as follows:

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflow
  • Predictive Genetic Testing & Preventive Medicine

On the basis of application, the global artificial intelligence (AI) in genomics market has been segmented as follows:

  • Diagnostics
  • Drug Discovery & Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other Applications

On the basis of end user, the global artificial intelligence (AI) in genomics market has been segmented as follows:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Healthcare Providers
  • Research Centers, Academic Institutes, & Government Organizations
  • Other End Users

On the basis of region, the global artificial intelligence (AI) in genomics market has been segmented as follows:

  • North America
  • Europe 
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
  • Rest of the World

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=36649899

The key stakeholders in the AI In Genomics market include:

  • Artificial intelligence (AI) in genomics solution providers
  • Platform providers
  • Technology providers
  • AI system providers
  • Medical research and biotechnology companies
  • Pharmaceutical companies and CROs
  • Hospitals and clinics
  • Universities and research organizations
  • Forums, alliances, and associations
  • Academic research institutes 
  • Healthcare institutions
  • Laboratories
  • Distributors
  • Venture capitalists
  • Government organizations
  • Institutional investors and investment banks
  • Investors/Shareholders
  • Consulting companies in the genomics sector
  • Raw material and component manufacturers
  • Non-profit organizations (NPOs)
  • Agri-genomics organizations
  • Direct-to-consumer genetic companies

Frequently Asked Questions (FAQs) of AI In Genomics Market:

Q1. What is the total market value of AI In Genomics Market report?

Q2. Which are the top companies holding the market share in AI In Genomics Market?

Q3. Which are the largest regions for this Market?

Q4. What is the leading technology of AI In Genomics Market?

Q5. What are the major drivers for this specific Market?

Q6. What are the upcoming key trends in the AI In Genomics Market report?

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=36649899

Recent Developments:

  • In December 2022, Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) completed of a joint research study using distributed machine learning (ML) and artificial intelligence (AI) approaches to help international healthcare and research institutions identify malignant brain tumors.
  • In September 20222, NVIDIA Corporation partnered with the Broad Institute of MIT and Harvard to accelerate Genome analysis workflows and help teams to co-develop large language models for the discovery and development of targeted therapies. The collaboration connects NVIDIA’s AI expertise and healthcare computing platforms with the Broad Institute’s researchers, scientists, and open platforms with a focus on Making NVIDIA Clara Parabricks available in the Terra platform, building large language models, and providing improved deep learning to Genome Analysis Toolkit (GATK).
  • In August 2021, Illumina, Inc. acquired GRAIL to provide patients with access to a potentially life-saving multi-cancer early-detection test.
  • In March 2021, SOPHiA GENETICS collaborated with Hitachi. This collaboration agreement offered clinical, genomic, and real-world insights to healthcare practitioners and pharmaceutical and biotechnology firms and to further democratize Data-Driven Precision Medicine internationally for the benefit of patients.

Related Reports:

Genomics Market

CRISPR Technology Market

Gene Editing Market

NGS-based RNA-sequencing Market

AI in Drug Discovery Market

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/artificial-intelligence-in-genomics-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/artificial-intelligence-in-genomics.asp


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

CoreWeave Invests £1 Billion in UK; Opens New European Headquarters and Data Centres in London to Bring Cloud Infrastructure to Power the AI Revolution

Published

on

coreweave-invests-1-billion-in-uk;-opens-new-european-headquarters-and-data-centres-in-london-to-bring-cloud-infrastructure-to-power-the-ai-revolution

LONDON, May 10, 2024 /PRNewswire/ — CoreWeave, the leading specialized cloud provider for AI, today announced that it has opened an office in London as its European headquarters as part of a broader expansion into the continent. The new UK expansion represents a £1 billion investment to bolster the country’s AI potential, and will create job opportunities across engineering, operations, finance and go-to-market. CoreWeave plans to open two UK data centres in 2024 with further expansion planned in 2025.

“We are seeing unprecedented demand for AI infrastructure and London is an important AI hub that we are investing in. Expanding our physical footprint in the UK is an important milestone in the next phase of CoreWeave’s growth,” said Mike Intrator, Cofounder and Chief Executive Officer, CoreWeave. “CoreWeave’s infrastructure will fill a void in the cloud market by providing AI enterprises with localized high-performance compute solutions that will help build and deploy the next generation of AI applications.”  
Prime Minister Rishi Sunak said: “Companies like CoreWeave are powering the future of AI innovation, and I am proud that they’ve backed the UK with a £1 billion investment into UK data centres and have established their European headquarters here – further cementing the UK’s position as an AI and tech superpower.
“We’re leaving no stone unturned to make the UK the best place for pioneering companies like CoreWeave to grow their roots. With the third highest number of AI companies and private investment in AI in the world, it’s clear our plan is working.”
Secretary of State of Science, Innovation, and Technology, Michelle Donelan said: “CoreWeave’s decision to base their European HQ here in London is not just a sign of our tech investment prowess, it is a resounding vote of confidence in our approach to AI and innovation. Today’s £1 billion investment will bring two new data centres to our shores, a vital tool in helping to develop the AI breakthroughs of tomorrow.
“It will also lead to new, highly paid jobs and countless opportunities for our brightest AI minds and start-ups as the UK continues to cement its global AI powerhouse credentials. Our message is clear – when it comes to investment, scaling-up, and innovation, the UK is the perfect home from home.”
CoreWeave’s new European headquarters in London is strategically located given the tremendous AI talent in the UK. The investment in the UK builds on the UK government’s established leadership fostering global awareness and engagement on responsible AI and the country’s commitment to drive investment with plans to upskill millions across the UK in AI. CoreWeave’s presence in the region will support the continued expansion of AI labs and enterprise customers across the UK, bringing much needed computing power to the UK.
CoreWeave’s existing data centres support some of the largest deployments of high-performance GPU clusters in the world, and the infrastructure through which those clusters are consumed is designed with engineers and innovators in mind. Trusted by leading AI labs and enterprises, CoreWeave Cloud manages complexity through automation to deliver the most performant and efficient cloud infrastructure for AI workloads.
About CoreWeave
CoreWeave is a specialized GPU cloud provider, designed to power the most complex workloads with customized solutions at scale. The company’s portfolio of cutting-edge technology delivers a broad range of capabilities for machine learning and AI, graphics and rendering, life sciences, real-time streaming, and more. Its world-class teams, talent, and engineering prowess bring unmatched speed-to-market for advanced compute. CoreWeave operates a growing footprint of data centers covering every region of the US. It was founded in 2017 and is based in New Jersey. Learn more at www.coreweave.com.
Contact
Jackson [email protected] 

View original content:https://www.prnewswire.co.uk/news-releases/coreweave-invests-1-billion-in-uk-opens-new-european-headquarters-and-data-centres-in-london-to-bring-cloud-infrastructure-to-power-the-ai-revolution-302141883.html

Continue Reading

Artificial Intelligence

Linnovate Partners Announces Close of USD 40 Million Funding Commitment Led by SeaTown

Published

on

linnovate-partners-announces-close-of-usd-40-million-funding-commitment-led-by-seatown

SINGAPORE, May 10, 2024 /PRNewswire/ — Linnovate Partners (“Linnovate”), a leader in asset servicing and fintech for the alternative investment industry, is pleased to announce the successful closure of USD 40 million funding commitment by SeaTown Private Capital Master Fund. SeaTown Private Capital Master Fund is managed by SeaTown Holdings International Pte. Ltd. (“SeaTown”), a leading Asia-focused alternative investments firm that is owned by Seviora, Temasek’s asset management group. This capital infusion marks a pivotal moment in Linnovate’s journey, enabling the firm to scale operations, drive innovation, and further solidify its position as a market leader.

As Linnovate continues to experience rapid growth and increasing demand for its tech-enabled services, the infusion of funds will play a vital role in meeting client requirements and advancing market innovation. The investment will enable Linnovate to allocate additional resources strategically, ensuring the company remains at the forefront of technology advancements and maintains its commitment to delivering exceptional solutions to clients worldwide.
Henry Lin, founder and CEO of Linnovate Partners, expressed enthusiasm about the opportunities this investment opens “We are thrilled to have SeaTown as our strategic partner and investor. This investment will be instrumental in accelerating our growth trajectory, providing us with the necessary resources to enhance our service offering, and continue delivering cutting-edge solutions to our clients and the industry itself.”
Dickson Loo, Managing Director of SeaTown, commented, “Linnovate has established itself to be an industry-leading player with their highly differentiated culture of customer centricity and strong technology focus. We are excited to be part of the next phase of Linnovate’s growth story, as we leverage our network, resources and expertise to help the company scale to greater heights”.
Linnovate has built a strong reputation for its innovative approach to solving manual mid-to-back-office tasks involved in fund administration through tech-enabled services. The company’s commitment to pushing the boundaries of technological advancement has earned it the trust of numerous high-profile private equity and venture capital firm clients and established it as a sought-after partner in the industry.
About Linnovate PartnersLinnovate Partners is a leading asset services provider focused on driving innovation in the alternative investments industry. With expertise across the entire fund lifecycle, Linnovate Partners goes beyond traditional fund administration to provide value-added services and technologies that empower asset and fund managers to excel in their operations. Its six core service areas include Fund Administration, Investor Relations, Regulatory Compliance, Portfolio Monitoring, Reporting Services and Technology Consulting Services.
Powering these services is a proprietary, cloud-based platform, RAISE, that provides all the functions of alternative investing in a single ecosystem and enables seamless integration and accessibility.
With offices globally, Linnovate Partners currently administers over $130 billion in assets across more than 600 private equity and venture capital funds. As an innovation-focused disruptor, Linnovate Partners combines deep industry expertise and the latest technologies to drive better outcomes for alternative investment managers and investors worldwide.
About SeaTown:Founded and headquartered in Singapore since 2009, SeaTown is a leading Asia-focused alternative investments firm with deep expertise across private and public markets.
Owned by Seviora, Temasek’s asset management group, SeaTown is a trusted steward of capital, investing alongside its investors in conviction-driven strategies. Its alternative investment fund platform offers international investors exposure to highly specialised private equity, private credit, and thematic absolute return opportunities in the region.
As a partner, SeaTown strives to deliver compelling risk-adjusted returns by leveraging its extensive relationship network, decades of investing experience and astute global perspectives.
For additional information, inquiries, or interview schedule, please contact:Linnovate Partners:Andrea [email protected]
SeaTown:Kayla [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/linnovate-partners-announces-close-of-usd-40-million-funding-commitment-led-by-seatown-302141238.html

Continue Reading

Artificial Intelligence

FinVolution to Hold 9th Global Data Science Competition, Focus on Deepfake Speech Detection in LLM era

Published

on

finvolution-to-hold-9th-global-data-science-competition,-focus-on-deepfake-speech-detection-in-llm-era

The 9th FinVolution Global Data Science Competition targets deepfake speech detection, tackling the challenge of distinguishing between cloned and authentic voices in the LLM era.The contest is part of the IJCAI 2024 Competitions and Challenges track, encouraging global collaboration and innovation among AI enthusiasts.By integrating LLM-generated fake voices in the test dataset, the competition increases complexity and spurs innovation.SHANGHAI, May 10, 2024 /PRNewswire/ — FinVolution, a leading fintech service provider, launches the 9th FinVolution Global Data Science Competition today, with a focus on “Deepfake Speech Detection.”  The contest is part of the IJCAI (International Joint Conference on Artificial Intelligence) Competitions and Challenges track, a top international AI conference.

As voice synthesis technology continues to evolve, the line between cloned and genuine voices has become increasingly blurred in the era of large language models (LLMs), posing significant challenges to data security and asset protection.
The competition aims to inspire global AI enthusiasts and experts to innovate in combating voice cloning and deepfake scams. Contestants will utilize deep learning technologies to develop models and algorithms based on FinVolution’s test dataset. The competition will include LLM-generated fake voices to elevate complexity and spur innovation.
With a total prize pool of RMB 310,000, the contest will consist of preliminaries, semifinals, and a final, with an aim to authenticate true and false voices. Highest-ranked contestants will attend IJCAI 2024 in Jeju of South Korea, to receive the awards and engage with academic and industry experts. FinVolution proudly sponsors IJCAI 2024.
Tiezheng Li, CEO of FinVolution, stated, “Since its inception nine years ago, the FinVolution Global Data Science Competition has evolved into a widely recognized event in the field of data technology, facilitating technical exchange worldwide. Partnering with IJCAI this year, a top-tier international AI conference, demonstrates our commitment to advancing deep speech recognition technology.”
The Deepfake Challenge
During the preliminaries (May 10 to June 12), participants will design algorithms based on the white-box dataset supplied by FinVolution and submit scoring results to qualify for the semifinals. The dataset primarily comprises voice recordings totaling 20-40 hours.
At the semifinal stage (June 13 to June 28), contenders are expected to refine their algorithms based on the black-box dataset provided by the competition organizer, vying for a spot in the final. The dataset, composed mainly of private data, contains five to 10 hours of recordings.
Participants can register on the official website from May 9 to June 3, to download and view the datasets.
Upholding AI Ethics
Voice cloning has emerged as a major form of telecom fraud, as scammers exploit AI technology to make distinction between genuine and fake voices increasingly tricky.
The competition focuses on safeguarding user privacy and combating fraudulent activities by identifying cloned voices accurately.
Lei Chen, Vice President of FinVolution and Head of its Big Data and AI Division, said, “The applications of Large Language Models far exceed the corresponding detection technology, posing great challenges to information security. We hope to see AI deepfake voice detection technology keep pace with the developments of LLMs, thus safeguarding the data security of the public. With this concept in mind, the FinVolution Global Data Science Competition is not only a platform for technical competition but also an opportunity to explore how AI can better adhere to ethical principles and serve the public.” 
To date, the FinVolution Global Data Science Competition has drawn nearly 10,000 participants globally in total, becoming a widely recognized event in the field of digital financial technology.
Organized annually since 2016, the contest themes have spanned diverse domains, all rooted in real-world fintech business scenarios. These themes range from risk control algorithms, financial data applications, and product development to semantic similarity recognition, asset portfolio cash flow prediction, and credit schemes for small- and micro-sized enterprises.
About FinVolution Group
FinVolution Group is a leading fintech company that connects millions of consumers as well as micro- and small-sized enterprises with financial institutions.
Founded in 2007 and listed on the New York Stock Exchange in 2017, we have been at the forefront of the pan-Asian credit technology industry, pioneering innovative technologies in credit risk assessment, fraud detection, big data, and artificial intelligence. With a proven track record of robust growth in pan-Asian countries, we have established leading fintech platforms in China, Indonesia, and the Philippines.
Photo –  https://mma.prnewswire.com/media/2408594/image_1.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/finvolution-to-hold-9th-global-data-science-competition-focus-on-deepfake-speech-detection-in-llm-era-302141074.html

Continue Reading

Trending